Fortitude Family Office’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-85
Closed -$4.01K – 2109
2025
Q3
$4.01K Sell
85
-8
-9% -$386 ﹤0.01% 885
2025
Q2
$4.49K Hold
93
– – ﹤0.01% 821
2025
Q1
$5.16K Sell
93
-477
-84% -$25.8K ﹤0.01% 720
2024
Q4
$27.5K Sell
570
-182
-24% -$9.25K 0.01% 380
2024
Q3
$43.3K Buy
752
+659
+709% +$35.6K 0.02% 270
2024
Q2
$4.51K Hold
93
– – ﹤0.01% 623
2024
Q1
$4.52K Hold
93
– – ﹤0.01% 652
2023
Q4
$4.63K Buy
+93
New +$4.55K ﹤0.01% 686

Other funds holding SNY

Fortitude Family Office's SNY Position: Q4 2025 in Review

Fortitude Family Office sold out of Sanofi (SNY) in Q4 2025, closing a stake of 85 shares — an estimated $4.01K sold.

Fortitude Family Office first reported a position in SNY in Q4 2023 and held it in 8 quarters. The position peaked at $43.3K in Q3 2024. 758 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

  • Fortitude Family Office reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
  • Fortitude Family Office sold 85 Sanofi shares in Q4 2025, an estimated $4.01K.
  • Fortitude Family Office first reported a position in Sanofi in Q4 2023 and held it in 8 quarters.
  • Fortitude Family Office's Sanofi position peaked at $43.3K in Q3 2024.
  • 758 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Fortitude Family Office's 13F filing for Q4 2025, filed 15 Jan 2026.